SCHEMBL19913159

SCHEMBL19913159

Cc1cccc(-c2ccc3c(c2)c2cc(-c4cccc(C)c4)ccc2n3-c2cc(C#N)cc(-n3c4ccc(-c5cccc(C)c5)cc4c4cc(-c5cccc(C)c5)ccc43)c2-c2ccncc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.45
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
GRIA2 P42262 1/20 0.37
GRIA4 P48058 1/20 0.37
SIRT2 Q8IXJ6 2/20 0.36
AR P10275 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
GRM5 P41594 1/20 0.35
CSNK1A1 P48729 1/20 0.35
CSNK1D P48730 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913154 0.96 MAPK14 (0.42) MAPK14CYP11B1CYP11B2GRIA2GRIA4
SCHEMBL19913158 0.91 MAPK14 (0.45) MAPK14CYP11B1CYP11B2GRIA2GRIA4
SCHEMBL19908959 0.91 GRM5 (0.39) MAPK14NPC1RAB9AGRM5CSNK1A1
SCHEMBL26776900 0.91 CYP11B1 (0.40) MAPK14CYP11B1CYP11B2GRIA2GRIA4
SCHEMBL19909067 0.90 MAPKAPK2 (0.39) MAPK14GRM5CSNK1A1CSNK1DALDH1A1
SCHEMBL19908927 0.90 AURKA (0.41) MAPK14GRM5CSNK1A1CSNK1DALDH1A1
SCHEMBL19913160 0.89 MAPK14 (0.42) MAPK14CYP11B1CYP11B2GRIA2GRIA4
SCHEMBL19908921 0.88 MKNK1 (0.40) MAPK14CYP11B2CSNK1A1CSNK1DMAPK11
SCHEMBL19913136 0.88 MAPK14 (0.37) MAPK14GRM5CSNK1A1CSNK1DKDM4E
SCHEMBL19908941 0.88 MAPK14 (0.41) MAPK14GRM5CSNK1A1CSNK1DFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 MAPK14 2544/4885CYP11B1 610/4885CYP11B2 402/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 MAPK14 2787/4885CYP11B1 1400/4885CYP11B2 965/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 MAPK14 2544/4885CYP11B1 610/4885CYP11B2 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.